Detalhe da pesquisa
1.
A pan-cancer analysis of the microbiome in metastatic cancer.
Cell
; 187(9): 2324-2335.e19, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599211
2.
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
Nature
; 613(7945): 743-750, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631610
3.
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
J Pathol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747304
4.
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Oncologist
; 29(5): 431-440, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109296
5.
The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP).
Acta Oncol
; 63: 368-372, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779868
6.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424386
7.
Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.
Oncologist
; 28(7): e493-e497, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086483
8.
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer
; 23(1): 205, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870947
9.
The DRUG Access Protocol: access inequality and European harmonisation - Authors' reply.
Lancet Oncol
; 23(5): e203, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489347
10.
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Lancet Oncol
; 23(2): 198-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114116
11.
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP).
Eur J Cancer
; 202: 113988, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471288
12.
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Lancet Reg Health Eur
; 39: 100875, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464480
13.
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol.
Clin Cancer Res
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630551
14.
Can Drug Repurposing Accelerate Precision Oncology?
Cancer Discov
; 12(7): 1634-1641, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35642948
15.
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Clin Cancer Res
; 28(7): 1402-1411, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046062
16.
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.
Clin Cancer Res
; 27(22): 6106-6114, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475104
17.
Maternal recall of a history of early-onset preeclampsia, late-onset preeclampsia, or gestational hypertension: a validation study.
Hypertens Pregnancy
; 39(4): 444-450, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981372